Akero Therapeutics, Inc. (AKRO)
USD 28.71
(-6.21%)
USD 28.71
(-6.21%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -145.36 Million | -92.51 Million | -79.68 Million | -70.8 Million | -35.62 Million | -4.62 Million |
| Net Income | -151.75 Million | -112.03 Million | -100.77 Million | -79.2 Million | -43.75 Million | -81.71 Million |
| Depreciation & Amortization | 29 Thousand | 43 Thousand | 41 Thousand | 17 Thousand | -104 Thousand | - |
| Deferred income taxes | 645 Thousand | - | 1.07 Million | 83 Thousand | 104 Thousand | - |
| Stock-based compensation | 21.49 Million | 23.24 Million | 10.05 Million | 6.02 Million | 1.77 Million | 121 Thousand |
| Change in working capital | -6.67 Million | -4.45 Million | 9.72 Million | 2.08 Million | 6.46 Million | 1.06 Million |
| Other non-cash items | -9.1 Million | 689 Thousand | 203 Thousand | 196 Thousand | -104 Thousand | 75.9 Million |
| Investing Cash Flow | -223.62 Million | -63.82 Million | 42.28 Million | -9.76 Million | -71.51 Million | -5 Million |
| Investments in PPE | - | - | - | -148 Thousand | - | -5 Million |
| Acquisitions | - | - | - | 9613.00 | - | - |
| Investment purchases | -433.12 Million | -101.44 Million | -43.56 Million | -115.03 Million | -71.51 Million | - |
| Sales/Maturities of investments | 209.5 Million | 37.62 Million | 85.84 Million | 105.42 Million | - | - |
| Other Investing Activities | -223.62 Thousand | -63.82 Thousand | 42.28 Thousand | -9613.00 | -71.51 Thousand | -5000.00 |
| Financing Cash Flow | 353.31 Million | 255.63 Million | 602 Thousand | 203.1 Million | 95.98 Million | 85 Million |
| Debt repayment | -15 Million | -9.26 Million | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | 396 Thousand | 280 Thousand | 373 Thousand | 198 Thousand | 85 Thousand | - |
| Common Stock Issuance | 338.31 Million | 246.36 Million | 602 Thousand | 203.05 Million | 95.45 Million | 85 Million |
| Other Financing Activities | 338.31 Million | -864 Thousand | 602 Thousand | 203.1 Million | 451 Thousand | 85 Million |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | -645 Thousand | 968 Thousand | 3.27 Million | 2.48 Million | -426 Thousand | 1.31 Million |
| Inventory | - | - | - | - | - | - |
| Other working capital | -6.02 Million | -5.42 Million | 6.45 Million | -396 Thousand | 6.88 Million | -252 Thousand |
| Cash at beginning of period | 249.77 Million | 150.59 Million | 187.39 Million | 64.84 Million | 76 Million | 618 Thousand |
| Cash at end of period | 234.2 Million | 249.88 Million | 150.59 Million | 187.39 Million | 64.84 Million | 76 Million |
| Capital Expenditure | - | - | - | -148 Thousand | - | -5 Million |
| Effect of forex changes on cash | 108 Thousand | - | - | - | - | - |
| Net cash flow / Change in cash | -15.56 Million | 99.29 Million | -36.79 Million | 122.54 Million | -11.15 Million | 75.38 Million |
| Free Cash Flow | -145.36 Million | -92.51 Million | -79.68 Million | -70.95 Million | -35.62 Million | -9.62 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -55.98 Million | -53.34 Million | -151.75 Million | -55.18 Million | -39.65 Million | -31.08 Million |
| Depreciation & Amortization | 1000.00 | 1000.00 | 29 Thousand | 2000.00 | 5000.00 | 11 Thousand |
| Deferred income taxes | - | - | 645 Thousand | 4.71 Million | -3.26 Million | -1.44 Million |
| Stock-based compensation | 7.65 Million | 7.39 Million | 21.49 Million | 6.11 Million | 5.73 Million | 4.79 Million |
| Change in working capital | -6.88 Million | 13.07 Million | -6.67 Million | 3.92 Million | -12.71 Million | 5.15 Million |
| Other non-cash items | 4.32 Million | -1.32 Million | -9.1 Million | -8.19 Million | 175 Thousand | 170 Thousand |
| Investing Cash Flow | -255.89 Million | 57.84 Million | -223.62 Million | 12.78 Million | -125.69 Million | -128.3 Million |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | -339.4 Million | -38.97 Million | -433.12 Million | -58.21 Million | -161.19 Million | -188.8 Million |
| Sales/Maturities of investments | 84.51 Million | 96.82 Million | 209.5 Million | 71 Million | 35.5 Million | 60.5 Million |
| Other Investing Activities | -999 Thousand | 57.84 Million | -223.62 Thousand | 12.78 Thousand | -125.69 Thousand | -128.3 Thousand |
| Financing Cash Flow | -150 Thousand | 366.93 Million | 353.31 Million | 502 Thousand | 806 Thousand | 336.85 Million |
| Debt repayment | - | -10 Million | -15 Million | -50 Thousand | - | -25 Thousand |
| Dividends payments | - | - | - | -336.85 Million | - | - |
| Common Stock Repurchased | - | - | 396 Thousand | -11.52 Billion | 5.75 Billion | - |
| Common Stock Issuance | -150 Thousand | 356.93 Million | 338.31 Million | 502 Thousand | 806 Thousand | 336.83 Million |
| Other Financing Activities | -477 Thousand | -274 Thousand | 338.31 Million | 502 Thousand | 806 Thousand | 336.85 Million |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | 1.09 Million | 6.45 Million | -645 Thousand | -4.22 Million | 1.33 Million | 2.87 Million |
| Inventory | - | - | - | - | - | - |
| Other working capital | -7.97 Million | 6.61 Million | -6.02 Million | 8.15 Million | -14.05 Million | 2.28 Million |
| Cash at beginning of period | 623.85 Million | 234.2 Million | 249.77 Million | 269.54 Million | 444.15 Million | 257.99 Million |
| Cash at end of period | 310.35 Million | 623.85 Million | 234.2 Million | 234.2 Million | 269.54 Million | 444.15 Million |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | - | - | 108 Thousand | -5.59 Billion | - | 5.59 Billion |
| Net cash flow / Change in cash | -313.49 Million | 389.64 Million | -15.56 Million | -35.33 Million | -174.61 Million | 186.16 Million |
| Free Cash Flow | -57.45 Million | -35.14 Million | -145.36 Million | -48.62 Million | -49.71 Million | -22.38 Million |
Z74
HMC
NAVKAR
3071
FORR
4194